JNJ - Johnson & Johnson
| Previous Close | 129.09 |
| Open | 129.90 |
| Bid | 130.10 x 1000 |
| Ask | 131.95 x 1800 |
| Day's Range | 129.45 - 131.18 |
| 52 Week Range | 118.62 - 148.99 |
| Volume | 10,592,972 |
| Avg. Volume | 9,833,629 |
| Market Cap | 350.508B |
| Beta (3Y Monthly) | 0.62 |
| PE Ratio (TTM) | 229.68 |
| EPS (TTM) | 0.57 |
| Earnings Date | Jan 22, 2019 |
| Forward Dividend & Yield | 3.60 (2.79%) |
| Ex-Dividend Date | 2019-02-25 |
| 1y Target Est | 145.50 |
Yahoo Finance•18 hours agoEarnings, Davos - What to know in the week ahead
World Economic Forum gathers in Davos, Switzerland, government shutdown continues and earnings week two, here's what you need to know next week.
- Zacks•2 hours ago
The Zacks Analyst Blog Highlights: Apple, Johnson & Johnson, Amazon and Alphabet
The Zacks Analyst Blog Highlights: Apple, Johnson & Johnson, Amazon and Alphabet
Motley Fool•19 hours ago3 Things to Watch in the Stock Market This Week
Starbucks, Procter & Gamble, and Johnson & Johnson shareholders have a lot to look forward to this week.
- Motley Fool•22 hours ago
Better Buy: AbbVie vs. Johnson & Johnson
Which stock wins in a one-on-one matchup between these two big drugmakers?
- Motley Fool•2 days ago
3 Stocks You Don't Realize You Use Every Day
From insurance to clothes, food, and medicine, these three juggernauts have you covered.
- CNBC•3 days ago
Cramer's game plan: This week, forecasts are more important than earnings
CNBC's Jim Cramer looks ahead at a busy week of earnings reports that he says might drive investors crazy. Johnson & Johnson, Comcast and Starbucks will be among the companies issuing quarterly results. "I can't recall a time when the forecast will be more important, certainly much more important than the results," Cramer, host of "Mad Money," told viewers.
- Motley Fool•3 days ago
What Happened in the Stock Market Today
The major benchmarks made gains, but Netflix fell despite reporting a strong quarter. Elsewhere, Apple and Johnson & Johnson announced a new collaboration.
- Zacks•3 days ago
Key Takeaways from Q4 Earnings Results Thus Far
Key Takeaways from Q4 Earnings Results Thus Far
- Zacks•3 days ago
Apple Expands in Healthcare, Partners Johnson & Johnson
Apple (AAPL) partners with Johnson & Johnson to conduct multi-year research study for early detection of irregular heart conditions.
- Motley Fool•3 days ago
Apple Watch and Johnson & Johnson Team Up for Heart Study
Can an app on the Apple Watch detect early signs of a heart ailment?
Yahoo Finance•3 days agoWalmart and CVS ink a deal, American Express falls short, Apple partners with pharma giant
Walmart, CVS, American Express, Apple, Johnson & Johnson, Rio Tinto and Tribune Publishing are the companies to watch.
- Reuters•3 days ago
AT&T ads returning to YouTube, 2 yrs after pulling back over content
AT&T Inc said Friday it will again buy advertising on Alphabet Inc's YouTube, nearly two years after the U.S. wireless carrier left the video platform when it discovered its ads may have appeared next to inappropriate content. AT&T is one of the largest U.S. brand marketers by total ad spend, according to research firm eMarketer, and its return caps off a tumultuous period for YouTube beginning in March 2017, when major advertisers including Verizon Communications Inc and Johnson & Johnson, left the platform after their ads played during videos featuring hate speech or other disturbing material. As brands eventually returned to YouTube, AT&T remained a major advertiser that held back.
- The Wall Street Journal•4 days ago
[$$] Johnson & Johnson to Use Apple Watch App for Heart-Health Study
Johnson & Johnson said Thursday that it has joined with Apple Inc. on a research study that will test the Apple Watch’s ability to help detect early irregular heart conditions in certain people before something life-threatening happens. Janssen Pharmaceuticals Inc., which is a part of J&J’s family of research and development companies, will work on the study. The company will use its J&J-developed heart health monitoring app on the latest Apple Watch series.
